Valuation (69%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -7.67 | 6.81 |
| PEG Ratio (TTM) | 0.01 | -0.79 |
| P/S Ratio (TTM) | 0.59 | 0.74 |
| P/B Ratio (TTM) | 0.85 | 1.15 |
| P/FCF Ratio (TTM) | -5.06 | 13.45 |
| Price to 5YR AVG Earnings Ratio | 1.23 | 6.79 |
| Price to 5YR AVG FCF Ratio | 1.52 | 7.18 |
Profitability (25%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -5.08% | 5.50% |
| ROE (TTM) | -10.66% | 8.55% |
| Net Profit Margin (TTM) | -6.33% | 5.55% |
| ROIC 5YR AVG | 34.40% | 19.37% |
Growth (38%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -539.65% | -393.62% | -262.03% |
| Revenue | -4.51% | 25.43% | 9.98% |
| Net Income | -541.35% | -0.91% | -26.54% |
| Cash Flow | 46.00% | 5,222.72% | 3,129.71% |
Health (67%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 3.31 | 2.45 |
| Quick Ratio (TTM) | 1.66 | 1.40 |
| D/E Ratio (TTM) | 0.44 | 0.33 |
| Interest Coverage (TTM) | -1.99 | 32.30 |
| Piotroski F-Score | 4 | 6 |
| Altman Z-Score | 1.24 | 3.36 |
| LTL to 5YR AVG FCF | 1.15 | 2.80 |
| Shares Outstanding Growth 5YR AVG | -12.59% | -3.62% |